Merck KGaA shares continued their recent recovery on Thursday following the quarterly report. With a gain of 5.8 percent to 156.60 euros, they took the lead in the slightly rising Dax. There was talk.
Press Release Nicox Provides Third Quarter 2022 Financial and Business Highlights Topline results of the NCX 470 Mont Blanc Phase 3 glaucoma trial due in.
Press Release Nicox Announces Last Patients Complete Final Visit in NCX 470 Phase 3 Mont Blanc Glaucoma Trial The last patients completed their final (3-month) visit on September 16691 patients
Press Release Nicox to Participate in Financial and Scientific Events in Q3 2022August 3, 2022 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA.